Medindia

X

EntreMed ENMD-2076 Phase 2 Data to Be Presented at ASCO Annual Meeting

Thursday, May 19, 2011 General News J E 4
Advertisement
ENMD-2076 Phase 2 Ovarian Cancer Study Accepted for Poster Discussion Session

-

Gynecologic Cancer Track:

Poster Session

Friday, June 3, 2011 – 2:00 p.m. - 6:00 p.m. (CDT) Abstract No.: 5021

Title: A Phase 2 Study of ENMD-2076 in platinum-resistant ovarian cancer

Poster Board: 10, Location: E450a

Discussion Session

Friday, June 3, 2011 – 5:00 p.m. - 6:00 p.m. (CDT)

Location: E354b

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Omeros Announces Clinical Development Programs for...
S
Shamir Optical Industry Reports First Quarter 2011...